相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
B. Zambrowicz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose-Absorption and Glucose-Dependent Incretin Secretion
Valentin Gorboulev et al.
DIABETES (2012)
Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin
O. Ljunggren et al.
DIABETES OBESITY & METABOLISM (2012)
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin
D. Devineni et al.
DIABETES OBESITY & METABOLISM (2012)
Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and Mice
Masayuki Suzuki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2
Charles S. Hummel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Early Growth Retardation and Insulin Resistance in JAZF1 KO Mice
Hui-Young Lee et al.
DIABETES (2011)
SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
Volker Vallon et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The Sweet Pee Model for Sglt2 Mutation
Joseph P. Ly et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Profound Obesity Secondary to Hyperphagia in Mice Lacking Kinase Suppressor of Ras 2
Jean-Pierre Revelli et al.
OBESITY (2011)
Biology of Human Sodium Glucose Transporters
Ernest M. Wright et al.
PHYSIOLOGICAL REVIEWS (2011)
Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes
Abd A. Tahrani et al.
Diabetes Therapy (2011)
SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
Michael J. Jurczak et al.
DIABETES (2011)
Carboxyl group-terminated polyamidoamine dendrimers bearing glucosides inhibit intestinal hexose transporter-mediated D-glucose uptake
Shinji Sakuma et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
SGLT2 inhibition - a novel strategy for diabetes treatment
Edward C. Chao et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
Jian Chen et al.
Diabetes Therapy (2010)
Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice
Ryuichi Moriya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
James F. List et al.
DIABETES CARE (2009)
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats
Yoshikazu Fujimori et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-Ay mice
Kenji Katsuno et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)
E-Chiang Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents
June Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Glucose Sensing in L Cells: A Primary Cell Study
Frank Reimann et al.
CELL METABOLISM (2008)
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
Songping Han et al.
DIABETES (2008)
Netrin-G2 and netrin-G2 ligand are both required for normal auditory responsiveness
W. Zhang et al.
GENES BRAIN AND BEHAVIOR (2008)
Polymer-phloridzin conjugates as an anti-diabetic drug that inhibits glucose absorption through the Na+/glucose cotransporter (SGLT1) in the small intestine
Yusuke Ikumi et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models
Yoshikazu Fujimori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion
Joaquim Calado et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
High-throughput screening of mouse knockout lines identifies true lean and obese phenotypes
Robert Brommage et al.
OBESITY (2008)
Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki rats
K Ueta et al.
LIFE SCIENCES (2005)
Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance
ZH Qi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Long-term outcome of renal glucosuria type 0:: the original patient and his natural history
S Scholl-Bürgi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention
BP Zambrowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular analysis of the SGLT2 gene in patients with renal glucosuria
R Santer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Knockouts model the 100 best-selling drugs - Will they model the next 100?
BP Zambrowicz et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
New drug targets for type 2 diabetes and the metabolic syndrome
DE Moller
NATURE (2001)
Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN
DB Donoviel et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na+-glucose cotransporter inhibitor T-1095
K Arakawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)